397 related articles for article (PubMed ID: 1920539)
1. Alteration of aflatoxin B1 metabolic profiles and reduction of aflatoxin B1 mutagenicity by hepatic microsomes of rats fed butylated hydroxyanisole.
Choi CY; Park SH; Park EH; Cha YN
J Toxicol Sci; 1991 Feb; 16 Suppl 1():119-32. PubMed ID: 1920539
[TBL] [Abstract][Full Text] [Related]
2. 2(3)-tert-butyl-4-hydroxyanisole inhibits oxidative metabolism of aflatoxin B1 in isolated rat hepatocytes.
Ch'ih JJ; Biedrzycka DW; Lin T; Khoo MO; Devlin TM
Proc Soc Exp Biol Med; 1989 Oct; 192(1):35-42. PubMed ID: 2508094
[TBL] [Abstract][Full Text] [Related]
3. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.
McLellan LI; Judah DJ; Neal GE; Hayes JD
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):117-24. PubMed ID: 8198522
[TBL] [Abstract][Full Text] [Related]
4. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
[TBL] [Abstract][Full Text] [Related]
5. Cytosol is required for the modulation by dietary casein of the hepatic microsomal activation of aflatoxin B1 to mutagenic metabolites detectable in Salmonella.
Woodall GM; Dauterman WC; Hagler WM; DeMarini DM
Mutagenesis; 1999 Jul; 14(4):365-73. PubMed ID: 10390503
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the effects of pretreatment with phenobarbitone and 3-methylcholanthrene on the metabolism of aflatoxin B1 by rat liver microsomes and isolated hepatocytes in vitro.
Metcalfe SA; Colley PJ; Neal GE
Chem Biol Interact; 1981 May; 35(2):145-57. PubMed ID: 6783328
[TBL] [Abstract][Full Text] [Related]
7. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
Raina V; Williams CJ; Gurtoo HL
Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse.
Monroe DH; Eaton DL
Toxicol Appl Pharmacol; 1987 Sep; 90(3):401-9. PubMed ID: 3116723
[TBL] [Abstract][Full Text] [Related]
9. Genotoxic and mutagenic activation of aflatoxin B1 by constitutive forms of cytochrome P-450 in rat liver microsomes.
Shimada T; Nakamura S; Imaoka S; Funae Y
Toxicol Appl Pharmacol; 1987 Oct; 91(1):13-21. PubMed ID: 3118508
[TBL] [Abstract][Full Text] [Related]
10. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
11. The effect of inducers of mixed-function oxidases on hepatic microsome-mediated aflatoxin B1 transformation in C3H/10T1/2 cells.
Faletto MB; Gurtoo HL
Toxicol Appl Pharmacol; 1989 Apr; 98(2):252-62. PubMed ID: 2496488
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of butylated hydroxyanisole on metabolism of aflatoxin B1 in vitro by liver and lung microsomes.
Allameh A; Saxena M; Raj HG
Cancer Lett; 1988 May; 40(1):49-57. PubMed ID: 3130980
[TBL] [Abstract][Full Text] [Related]
13. Comparative effect of dietary butylated hydroxyanisole and beta-naphthoflavone on aflatoxin B1 metabolism, DNA adduct formation, and carcinogenesis in rainbow trout.
Goeger DE; Shelton DW; Hendricks JD; Pereira C; Bailey GS
Carcinogenesis; 1988 Oct; 9(10):1793-800. PubMed ID: 3139317
[TBL] [Abstract][Full Text] [Related]
14. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.
Neal GE; Eaton DL; Judah DJ; Verma A
Toxicol Appl Pharmacol; 1998 Jul; 151(1):152-8. PubMed ID: 9705898
[TBL] [Abstract][Full Text] [Related]
16. Butylated hydroxyanisole, butylated hydroxytoluene and tert.-butylhydroquinone are not mutagenic in the Salmonella/microsome assay using new tester strains.
Hageman GJ; Verhagen H; Kleinjans JC
Mutat Res; 1988 Jul; 208(3-4):207-11. PubMed ID: 3041273
[TBL] [Abstract][Full Text] [Related]
17. Effect of butylated hydroxyanisole pretreatment on in vitro hepatic aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation in rats.
Jhee EC; Ho LL; Lotlikar PD
Cancer Res; 1988 May; 48(10):2688-92. PubMed ID: 3129185
[TBL] [Abstract][Full Text] [Related]
18. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
Walters JM; Combes RD
Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
[TBL] [Abstract][Full Text] [Related]
19. Mutagenic activation of aflatoxin B1 by pulmonary, renal, and hepatic cytochrome P450s from rats.
Imaoka S; Ikemoto S; Shimada T; Funae Y
Mutat Res; 1992 Oct; 269(2):231-6. PubMed ID: 1383706
[TBL] [Abstract][Full Text] [Related]
20. Modulation of aflatoxin B1 biotransformation in rabbit pulmonary and hepatic microsomes.
Daniels JM; Massey TE
Toxicology; 1992 Aug; 74(1):19-32. PubMed ID: 1514185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
